Sign up to save your podcasts
Or
Share The Danish Company Behind Ozempic
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Danish Company Behind Ozempic
The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Foreign Policy
4.7
277277 ratings
The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Ones and Tooze
View all
Behind the News with Doug Henwood
492 Listeners
The LRB Podcast
293 Listeners
Jacobin Radio
1,399 Listeners
Foreign Policy Live
591 Listeners
The Dig
1,520 Listeners
Odd Lots
1,781 Listeners
Bungacast
211 Listeners
Politics Theory Other
153 Listeners
The Rhodes Center Podcast with Mark Blyth
58 Listeners
Know Your Enemy
1,904 Listeners
I Spy
2,726 Listeners
The Rachman Review
138 Listeners
Heat of the Moment
27 Listeners
What's Left of Philosophy
262 Listeners
Counterpoint
36 Listeners
The Hidden Economics of Remarkable Women (HERO)
206 Listeners
The Long Game: Sports Stories of Courage and Conviction
13 Listeners
The Foreign Affairs Interview
412 Listeners
The Catch
73 Listeners
Macrodose
27 Listeners
Foreign Policy Playlist
0 Listeners
Editor's Roundtable
2 Listeners
First Person
0 Listeners
Past Present Future
318 Listeners
Everyday Ambassador
8 Listeners
Can We End Epidemics?
0 Listeners
State of Seed
8 Listeners